Patent Assignment
Reel/Frame 018676/0439
Settlement Agreement
Recorded: 2006-12-18
Pages: 21
Assignors
ELAN CORPORATION, PLC
Executed: 2006-12-07
ELAN PHARMA INTERNATIONAL, LTD.
Executed: 2006-12-07
ELAN PHARMACEUTICALS, INC.
Executed: 2006-12-07
EISEI INC.
Executed: 2006-12-12
EISAI CO., LTD.
Executed: 2006-12-14
JENNINGS, JULIANNE E.
Executed: 2006-12-11
Assignees
DUKE UNIVERSITY
DURHAM, NORTH CAROLINA, 27708
OREXIGEN THERAPEUTICS, INC.
12481 HIGH BLUFF DRIVE, SUITE 160, SAN DIEGO, CALIFORNIA, 92130
Covered Properties
(3)
Zonisamide use in obesity and eating disorders
Application:
10/429,474 →
Publication:
US 2004/0029941
Zonisamide use in eating disorders
Application:
10/932,047 →
Publication:
US 2005/0026977
Zonisamide use in obesity and eating disorders
Application:
60/378,446 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 23, 2003
From: JENNINGS, JULIANNE E.
To: ELAN PHARMACEUTICALS, INC.
Reel/Frame 014534/0820 →
Assignment of Assignor's Interest
Jul 16, 2004
From: ELAN PHARMACEUTICALS, INC.; ELAN PHARMA INTERNATIONAL LIMITED
To: EISAI, INC.
Reel/Frame 015568/0903 →
Security Agreement
Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →